These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1533561)

  • 1. Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease.
    Mateo D; Muñoz-Blanco JL; Giménez-Roldán S
    Clin Neuropharmacol; 1992 Feb; 15(1):63-8. PubMed ID: 1533561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome induced by combination therapy with tetrabenazine and tiapride in a Japanese patient with Huntington's disease at the terminal stage of recurrent breast cancer.
    Nozaki I; Furukawa Y; Kato-Motozaki Y; Ikeda T; Tagami A; Takahashi K; Ishida C; Komai K
    Intern Med; 2014; 53(11):1201-4. PubMed ID: 24881749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrabenazine as a cause of neuroleptic malignant syndrome.
    Ossemann M; Sindic CJ; Laterre C
    Mov Disord; 1996 Jan; 11(1):95. PubMed ID: 8771075
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome after neuroleptic discontinuation.
    Amore M; Zazzeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.
    Toglia JU; McGlamery M; Sambandham RR
    J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
    Spivak B; Weizman A; Wolovick L; Hermesh H; Tyano S; Munitz H
    Acta Psychiatr Scand; 1990 Feb; 81(2):168-9. PubMed ID: 1970216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
    Giménez-Roldán S; Mateo D
    Neurologia; 1989 Oct; 4(8):282-7. PubMed ID: 2534679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.
    Burke RE; Fahn S; Mayeux R; Weinberg H; Louis K; Willner JH
    Neurology; 1981 Aug; 31(8):1022-5. PubMed ID: 6115336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrabenazine in the treatment of Huntington's chorea.
    Huang CY; McLeod JG; Holland RT; Elliot C
    Med J Aust; 1976 Apr; 1(16):583-4. PubMed ID: 132600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
    Reeves RR; Mack JE; Torres RA
    Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome from treatment with antidepressives].
    Heinemann F; Assion HJ; Laux G
    Fortschr Neurol Psychiatr; 1997 May; 65(5):208-13. PubMed ID: 9235312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
    Röther J; Jakob J; Bender HJ; Hewer W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrabenazine for Huntington's chorea.
    Soutar CA
    Br Med J; 1970 Oct; 4(5726):55. PubMed ID: 4248502
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prolonged neuroleptic malignant syndrome after Haloperidol injection].
    Wystub N; Heymel S; Fritzenwanger M; Schulze PC; Pfeifer R
    Med Klin Intensivmed Notfmed; 2018 Apr; 113(3):212-216. PubMed ID: 28752347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tetrabenazine for Huntington's disease-associated chorea.
    Poon LH; Kang GA; Lee AJ
    Ann Pharmacother; 2010 Jun; 44(6):1080-9. PubMed ID: 20442355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome.
    Ansseau M; Reynolds CF; Kupfer DJ; Poncelet PF; Franck G; Dresse AE; Reznik M
    J Clin Psychiatry; 1986 Jun; 47(6):320-1. PubMed ID: 3011760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.